Acquired factor VII deficiency causing severe bleeding disorder secondary to AL amyloidosis of the liver
暂无分享,去创建一个
[1] Giampaolo Merlini,et al. Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines , 2016, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[2] K. Devreese,et al. Isolated acquired factor VII deficiency: review of the literature , 2016, Acta clinica Belgica.
[3] P. Hawkins,et al. Utility of factor X concentrate for the treatment of acquired factor X deficiency in systemic light-chain amyloidosis. , 2014, Blood.
[4] G. Merlini,et al. Systemic light chain amyloidosis: an update for treating physicians. , 2013, Blood.
[5] B. Hazenberg. Amyloidosis: a clinical overview. , 2013, Rheumatic diseases clinics of North America.
[6] M. Albayrak,et al. Acquired Factor VII deficiency associated with pneumonia , 2011 .
[7] G. Mariani,et al. Factor VII Deficiency , 2009, Seminars in thrombosis and hemostasis.
[8] B. Brenner,et al. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency , 2007, Hematology.
[9] B. Grabensee,et al. Amyloidosis and bleeding: pathophysiology, diagnosis, and therapy. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] Nomenclature Guidelines , 2006 .
[11] C. Mullighan,et al. Acquired isolated factor VII deficiency associated with severe bleeding and successful treatment with recombinant FVIIa (NovoSeven) , 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[12] K. Takenaka,et al. Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis. , 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[13] M. Skinner,et al. Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy. , 2001, Blood.
[14] K. Reddy,et al. Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study. , 1997, Gastroenterology.
[15] U. Hedner,et al. Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders. , 1993, Transfusion medicine reviews.
[16] L. Poller,et al. Factor VII as a marker of hepatocellular synthetic function in liver disease. , 1976, Journal of clinical pathology.
[17] Y. Dahlan,et al. Liver Amyloidosis Complicated with Liver Failure: A Case Report and Review of the Literature , 2011 .